Charrel Rémi N, Leparc-Goffart Isabelle, Pas Suzan, de Lamballerie Xavier, Koopmans Marion, Reusken Chantal
UMR EPV Emergence des Pathologies Virales, Aix Marseille Université, Marseille, France.
French National Reference Centre for Arbovirus, Armed Forces Biomedical Research Institute, Marseille, France .
Bull World Health Organ. 2016 Aug 1;94(8):574-584D. doi: 10.2471/BLT.16.171207.
To review the state of knowledge about diagnostic testing for Zika virus infection and identify areas of research needed to address the current gaps in knowledge.
We made a non-systematic review of the published literature about Zika virus and supplemented this with information from commercial diagnostic test kits and personal communications with researchers in European preparedness networks. The review covered current knowledge about the geographical spread, pathogen characteristics, life cycle and infection kinetics of the virus. The available molecular and serological tests and biosafety issues are described and discussed in the context of the current outbreak strain.
We identified the following areas of research to address current knowledge gaps: (i) an urgent assessment of the laboratory capacity and capability of countries to detect Zika virus; (ii) rapid and extensive field validation of the available molecular and serological tests in areas with and without Zika virus transmission, with a focus on pregnant women; (iii) monitoring the genomic diversity of circulating Zika virus strains; (iv) prospective studies into the virus infection kinetics, focusing on diagnostic sampling (specimen types, combinations and timings); and (v) developing external quality assessments for molecular and serological testing, including differential diagnosis for similar viruses and symptom clusters. The availability of reagents for diagnostic development (virus strains and antigens, quantified viral ribonucleic acid) needs to be facilitated.
An international laboratory response is needed, including preparation of protocols for prospective studies to address the most pressing information needs.
回顾寨卡病毒感染诊断检测的知识现状,并确定为填补当前知识空白所需开展研究的领域。
我们对已发表的关于寨卡病毒的文献进行了非系统性综述,并辅以商业诊断试剂盒的信息以及与欧洲防范网络研究人员的个人交流。该综述涵盖了关于病毒地理传播、病原体特征、生命周期和感染动力学的现有知识。在当前疫情毒株的背景下,对现有的分子和血清学检测方法以及生物安全问题进行了描述和讨论。
我们确定了以下几个研究领域以填补当前知识空白:(i)对各国检测寨卡病毒的实验室能力进行紧急评估;(ii)在有和没有寨卡病毒传播的地区,对现有的分子和血清学检测方法进行快速且广泛的现场验证,重点关注孕妇;(iii)监测传播中的寨卡病毒毒株的基因组多样性;(iv)对病毒感染动力学进行前瞻性研究,重点关注诊断采样(样本类型、组合和时间);以及(v)开展分子和血清学检测的外部质量评估,包括对相似病毒和症状群的鉴别诊断。需要推动用于诊断开发的试剂(病毒毒株和抗原、定量病毒核糖核酸)的供应。
需要开展国际实验室应对行动,包括制定前瞻性研究方案以满足最紧迫的信息需求。